Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysisAdela Escudero, Guillermo Villacampa, Alfonso López de Sá et al.|Cancer Treatment Reviews|2025Cited by 3